Zobrazeno 1 - 2
of 2
pro vyhledávání: '"NK and T cell Activation"'
Autor:
Srivastava MK, Zhu L, Harris-White M, Huang M, St John M, Lee JM, Salgia R, Cameron RB, Strieter R, Dubinett S, Sharma S
Publikováno v:
ImmunoTargets and Therapy, Vol 2012, Iss Issue 1, Pp 7-12 (2012)
Minu K Srivastava,1,2 Li Zhu,1,2 Marni Harris-White,2 Min Huang,1–3 Maie St John,1,3 Jay M Lee,1,3 Ravi Salgia,4 Robert B Cameron,1,3,5 Robert Strieter,6 Steven Dubinett,1–3 Sherven Sharma1–31Department of Medicine, UCLA Lung Cancer Research Pr
Externí odkaz:
https://doaj.org/article/26942563f14049a2b05e15c679f74231
Autor:
Maria Pia Pistillo, Nicoletta Ferrari, Vincenzo Fontana, Anna Morabito, Alessandro Poggi, Simona Boccardo, Sandra Salvi, Gabriella Pietra, Simona Minghelli, Maria Cristina Mingari, Patrizia Piccioli, Guido Ferlazzo, Stefania Laurent, Silvia Boero, Francesca Tosetti, Lung Ji Chang, Paola Queirolo, Paolo Carrega
Publikováno v:
Scopus-Elsevier
Journal of Translational Medicine
Journal of Translational Medicine
Background CTLA-4 (Cytotoxic T lymphocyte antigen-4) is traditionally known as a negative regulator of T cell activation. The blocking of CTLA-4 using human monoclonal antibodies, such as Ipilimumab, is currently used to relieve CTLA-4-mediated inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ac9ee5d76fcbd689113cd516046712d
http://www.scopus.com/inward/record.url?eid=2-s2.0-84876810947&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84876810947&partnerID=MN8TOARS
